F
Forbion
Activity from announced rounds
Activity in this selectionApr 30, 2025 · Apr 1, 2025
Forbion is an investment firm whose official portfolio and financing news identify CellCentric, Sling and Solstice.
Recorded funding activity
Sling develops an oral medicine for thyroid eye disease. Solstice advances an engineered cancer-immunotherapy antibody, while RQ Bio develops preventive antibodies for vulnerable patients facing influenza. These are separate clinical programs and company financings.
Sources
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.